http://www.unboundmedicine.com/medline/ebm/research/SeroquelUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19049484/full_citation/Paradoxical_and_severe_hypotension_in_response_to_adrenaline_infusions_in_massive_quetiapine_overdose_Hawkins DJ, Unwin P 
Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose. [Journal Article]
Crit Care Resusc 2008 Dec; 10(4):322.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19047843/full_citation/Drug_induced_liver_injury:_hepatotoxicity_of_quetiapine_revisited_Shpaner A, Li W, Ankoma-Sey V, et al. 
Drug-induced liver injury: hepatotoxicity of quetiapine revisited. [Journal Article]
Eur J Gastroenterol Hepatol 2008 Nov; 20(11):1106-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19036233/full_citation/Dosing_Quetiapine_in_Drug_Naive_First_Episode_Psychosis:_A_Controlled_Double_Blind_Randomized_Single_Center_Study_Investigating_Efficacy_Tolerability_and_Safety_of_200_mg/day_vs__400_mg/day_of_Quetiapine_Fumarate_in_141_Patients_Aged_15_to_25_Years_Berger GE, Proffitt TM, McConchie M, et al. 
Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years. [JOURNAL ARTICLE]
J Clin Psychiatry 2008 Nov 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19034754/full_citation/Quetiapine_in_patients_with_borderline_personality_disorder:_an_open_label_trial_Romine A, Brown E, Thuras P, et al. 
Quetiapine in patients with borderline personality disorder: an open-label trial. [Journal Article]
Ann Clin Psychiatry 2008 Oct-Dec; 20(4):219-26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19028375/full_citation/Hospitalization_risk_associated_with_typical_and_atypical_antipsychotic_use_in_community_dwelling_elderly_patients_Aparasu RR, Jano E, Johnson ML, et al. 
Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. [Journal Article]
Am J Geriatr Pharmacother 2008 Oct; 6(4):198-204.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19027269/full_citation/Results_of_phase_3_of_the_CATIE_schizophrenia_trial_Stroup TS, Lieberman JA, McEvoy JP, et al. 
Results of phase 3 of the CATIE schizophrenia trial. [JOURNAL ARTICLE]
Schizophr Res 2008 Nov 20.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19025425/full_citation/Prioritizing_Future_Research_on_Off_Label_Prescribing:_Results_of_a_Quantitative_Evaluation_Walton SM, Schumock GT, Lee KV, et al. 
Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation. [JOURNAL ARTICLE]
Pharmacotherapy 2008 Dec; 28(12):1443-1452.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19022943/full_citation/Metabolism_of_quetiapine_by_CYP3A4_and_CYP3A5_in_presence_or_absence_of_cytochrome_b5_Bakken GV, Rudberg I, Christensen H, et al. 
Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome b5. [JOURNAL ARTICLE]
Drug Metab Dispos 2008 Nov 20.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19015230/full_citation/A_Meta_Analysis_of_Head_to_Head_Comparisons_of_Second_Generation_Antipsychotics_in_the_Treatment_of_Schizophrenia_Leucht S, Komossa K, Rummel-Kluge C, et al. 
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia. [JOURNAL ARTICLE]
Am J Psychiatry 2008 Nov 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19012820/full_citation/Long_Term_Antipsychotic_Monotherapy_for_Schizophrenia:_Disease_Burden_and_Comparative_Outcomes_for_Patients_Treated_With_Olanzapine_Quetiapine_Risperidone_or_Haloperidol_Monotherapy_in_a_Pan_Continental_Observational_Study_Dossenbach M, Pecenak J, Szulc A, et al. 
Long-Term Antipsychotic Monotherapy for Schizophrenia: Disease Burden and Comparative Outcomes for Patients Treated With Olanzapine, Quetiapine, Risperidone, or Haloperidol Monotherapy in a Pan-Continental Observational Study. [JOURNAL ARTICLE]
J Clin Psychiatry 2008 Nov 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles